Streetbeat News

Analyst Ratings

UNH

UnitedHealth Group (UNH) reported Q2 profits of $5.5 billion, up 8% Y/Y, leading Oppenheimer analyst Michael Wiederhorn to reiterate an Outperform rating with a price target of $610. Despite rising costs, UNH's health insurance plans and Optum medical provider businesses grew by double-digit percentages. The company also raised the lower end of its FY2023 guidance range. Post-Q2, Wiederhorn adjusted FY2023/2024/2025 EPS estimates slightly.

Portfolio Pulse from Nabaparna Bhattacharya

July 17, 2023 | 7:25 pm

ALB

A significant amount of unusual options activity has been observed for Albemarle (NYSE:ALB), with a bearish stance being taken by a majority of investors. Of the 10 strange trades detected, 70% were bearish and 30% bullish. The total amount for the 2 puts was $225,970 and for the 8 calls was $689,002. Whales have been targeting a price range from $135.0 to $390.0 for Albemarle over the last 3 months. Morgan Stanley has downgraded its action to Underweight with a price target of $155, while Keybanc maintains their Overweight rating with a price target of $291.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:17 pm

DAL

A large investor has taken a bullish stance on Delta Air Lines (NYSE:DAL), with 19 uncommon options trades spotted. The sentiment of these trades is split between 52% bullish and 47% bearish. Whales have been targeting a price range from $32.0 to $52.5 for Delta Air Lines over the last 3 months. Several financial institutions have maintained their positive ratings on Delta Air Lines, with price targets ranging from $48 to $77.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:17 pm

DV

META

JMP Securities analyst Andrew Boone has raised the price target on DoubleVerify Holdings Inc (DV) to $45 from $35, reiterating Market Outperform. Boone sees a $90 million opportunity in the anticipated verification launch by Meta Platforms Inc (META) and DoubleVerify by the end of 2023. However, due to uncertainty around the rollout, only $40 million of this has been incorporated into 2024 projections. Boone expects the contribution margin for Meta brand safety revenue to be at least 80%.

Portfolio Pulse from Lekha Gupta

July 17, 2023 | 7:07 pm

C

Oppenheimer analyst Chris Kotowski has reiterated an Outperform rating on Citigroup, Inc. (NYSE:C), increasing the price target to $88 from $84. Despite a 1% YoY decline in Q2 FY23 net revenue to $19.44 billion, the figure beat the consensus of $19.27 billion. EPS was also above consensus at $1.33. Citigroup completed a billion dollars of share buy-backs this quarter, reducing the share count since 2015 by 35%. The bank expects FY23 adjusted revenue of $78 billion - $79 billion.

Portfolio Pulse from Nabaparna Bhattacharya

July 17, 2023 | 7:06 pm

JNJ

A significant investor has taken a bearish stance on Johnson & Johnson (NYSE:JNJ), with 90% of recent trades being bearish. The trades range from $105.0 to $175.0. The price of JNJ is currently down -0.39% at $159.24. Cantor Fitzgerald has downgraded its action to Overweight with a price target of $215, while Morgan Stanley maintains an Equal-Weight rating with a price target of $187.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:01 pm

PFE

A significant investor has taken a bearish stance on Pfizer (NYSE:PFE), with 53% of recent trades being bearish and 46% bullish. The total amount for put options was $1,310,868 and for call options $253,745. Whales have been targeting a price range from $25.0 to $40.0 for Pfizer over the last 3 months. Pfizer's current price is $36.04, down 0.77%. Several financial institutions have downgraded their actions on Pfizer, with price targets ranging from $40 to $75.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:01 pm

AXSM

Over the past 3 months, 11 analysts have published their opinion on Axsome Therapeutics (NASDAQ:AXSM) stock. The company has an average price target of $115.45 with a high of $200.00 and a low of $87.00. The average price target has increased by 6.11% over the past month.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:01 pm

PTLO

Over the past 3 months, 4 analysts have published their opinion on Portillos (NASDAQ:PTLO) stock, with an average price target of $25.5 versus the current price of $22.85. The average price target has increased by 4.81% over the past month. The analysts are generally bullish on the stock.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:01 pm

BG

Four analysts have provided ratings for Bunge (NYSE:BG) in the last quarter, with one bullish, two somewhat bullish, and one indifferent. The average price target is $121.0, compared to Bunge's current price of $101.44, implying an upside. The average price target has increased by 5.22% over the past month.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:00 pm